BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  BioXcel Therapeutics Provides Clinical and Business Update

  February 5, 2025

   · 

  12 min read
• Press Releases

  Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

  February 5, 2025

   · 

  1 min read
• Press Releases

  Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025

  February 5, 2025

   · 

  1 min read
• Press Releases

  Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

  February 5, 2025

   · 

  6 min read
• Press Releases

  Cencora Reports Fiscal 2025 First Quarter Results

  February 5, 2025

   · 

  19 min read
• Press Releases

  Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025

  February 5, 2025

   · 

  5 min read
• Press Releases

  EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints

  February 5, 2025

   · 

  14 min read
• Press Releases

  Gradalis Secures FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Vigil® (Gemogenovatucel-T): An Investigational Personalized Immunotherapy for Advanced Ovarian Cancer

  February 5, 2025

   · 

  6 min read
• Press Releases

  Marengo Therapeutics Announces the Appointment of Elena Garralda, MD, PhD, to its Scientific Advisory Board

  February 5, 2025

   · 

  2 min read
• Press Releases

  Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

  February 5, 2025

   · 

  24 min read